Donafenib-Loaded Callispheres Beads Embolization in a VX2 Liver Tumor: Investigating Efficacy, Safety, and Improvement of Tumor Angiogenesis After Embolization
Tongqiang Li,1,2,* Qin Shi,1,2,* Jiacheng Liu,1,2,* Yingliang Wang,1,2 Chen Zhou,1,2 Chaoyang Wang,1,2 Shuguang Ju,1,2 Songjiang Huang,1,2 Chongtu Yang,1,2 Yang Chen,1,2 Yaowei Bai,1,2 Bin Xiong1,2 1Department of Radiology, Union Hospital, Tongji Medical College, Huazhong Uni...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5852c3c6defc41ddbb167c0395106f11 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:5852c3c6defc41ddbb167c0395106f11 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:5852c3c6defc41ddbb167c0395106f112021-12-02T19:17:36ZDonafenib-Loaded Callispheres Beads Embolization in a VX2 Liver Tumor: Investigating Efficacy, Safety, and Improvement of Tumor Angiogenesis After Embolization2253-5969https://doaj.org/article/5852c3c6defc41ddbb167c0395106f112021-12-01T00:00:00Zhttps://www.dovepress.com/donafenib-loaded-callispheres-beads-embolization-in-a-vx2-liver-tumor--peer-reviewed-fulltext-article-JHChttps://doaj.org/toc/2253-5969Tongqiang Li,1,2,* Qin Shi,1,2,* Jiacheng Liu,1,2,* Yingliang Wang,1,2 Chen Zhou,1,2 Chaoyang Wang,1,2 Shuguang Ju,1,2 Songjiang Huang,1,2 Chongtu Yang,1,2 Yang Chen,1,2 Yaowei Bai,1,2 Bin Xiong1,2 1Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People’s Republic of China; 2Hubei Province Key Laboratory of Molecular Imaging, Wuhan, 430022, People’s Republic of China*These authors contributed equally to this workCorrespondence: Bin XiongDepartment of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Avenue #1277, Wuhan, 430022, People’s Republic of ChinaEmail herr_xiong@126.comObjective: To investigate the efficiency and safety of callispheres beads loaded with donafenib (DCBs) for embolization in a VX2 liver tumor, as well as the improvement of tumor angiogenesis following embolization.Methods: Forty New Zealand white rabbit VX2 liver tumors were treated with four different drugs via the hepatic artery: NS (normal saline), CB (blank callispheres beads), ACB (adriamycin-loaded callispheres beads) and DCB (DCBs). Hematoxylin-eosin staining was performed to assess tumor necrosis, while MRI was employed to detect the changes in tumor size. The safety was evaluated by the liver and kidney function parameters, and the immunofluorescence and immunohistochemical staining were performed to reflect the tumor hypoxia and tumor angiogenesis following embolization.Results: The DCB group had the smallest tumor growth rate, but the tumor necrosis rate was the highest of the four groups. Compared to the CB and ACB groups, the DCB group did not aggravate the liver damage and had no influence on kidney function. The staining results showed that, although the tumor hypoxia deteriorated after DCBs embolization, the expression of VEGF (vascular endothelial growth factor) reduced, thus inhibiting tumor angiogenesis.Conclusion: DCB administration via hepatic artery is an effective and safe treatment for a preclinical liver cancer model, with the unique benefit of suppressing tumor angiogenesis following embolization.Keywords: hepatocellular carcinoma, donafenib, transcatheter arterial chemoembolization, tumor angiogenesis, efficacy, safetyLi TShi QLiu JWang YZhou CWang CJu SHuang SYang CChen YBai YXiong BDove Medical Pressarticlehepatocellular carcinomadonafenibtranscatheter arterial chemoembolizationtumor angiogenesisefficacysafety;Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENJournal of Hepatocellular Carcinoma, Vol Volume 8, Pp 1525-1535 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
hepatocellular carcinoma donafenib transcatheter arterial chemoembolization tumor angiogenesis efficacy safety; Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
hepatocellular carcinoma donafenib transcatheter arterial chemoembolization tumor angiogenesis efficacy safety; Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Li T Shi Q Liu J Wang Y Zhou C Wang C Ju S Huang S Yang C Chen Y Bai Y Xiong B Donafenib-Loaded Callispheres Beads Embolization in a VX2 Liver Tumor: Investigating Efficacy, Safety, and Improvement of Tumor Angiogenesis After Embolization |
description |
Tongqiang Li,1,2,* Qin Shi,1,2,* Jiacheng Liu,1,2,* Yingliang Wang,1,2 Chen Zhou,1,2 Chaoyang Wang,1,2 Shuguang Ju,1,2 Songjiang Huang,1,2 Chongtu Yang,1,2 Yang Chen,1,2 Yaowei Bai,1,2 Bin Xiong1,2 1Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People’s Republic of China; 2Hubei Province Key Laboratory of Molecular Imaging, Wuhan, 430022, People’s Republic of China*These authors contributed equally to this workCorrespondence: Bin XiongDepartment of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Avenue #1277, Wuhan, 430022, People’s Republic of ChinaEmail herr_xiong@126.comObjective: To investigate the efficiency and safety of callispheres beads loaded with donafenib (DCBs) for embolization in a VX2 liver tumor, as well as the improvement of tumor angiogenesis following embolization.Methods: Forty New Zealand white rabbit VX2 liver tumors were treated with four different drugs via the hepatic artery: NS (normal saline), CB (blank callispheres beads), ACB (adriamycin-loaded callispheres beads) and DCB (DCBs). Hematoxylin-eosin staining was performed to assess tumor necrosis, while MRI was employed to detect the changes in tumor size. The safety was evaluated by the liver and kidney function parameters, and the immunofluorescence and immunohistochemical staining were performed to reflect the tumor hypoxia and tumor angiogenesis following embolization.Results: The DCB group had the smallest tumor growth rate, but the tumor necrosis rate was the highest of the four groups. Compared to the CB and ACB groups, the DCB group did not aggravate the liver damage and had no influence on kidney function. The staining results showed that, although the tumor hypoxia deteriorated after DCBs embolization, the expression of VEGF (vascular endothelial growth factor) reduced, thus inhibiting tumor angiogenesis.Conclusion: DCB administration via hepatic artery is an effective and safe treatment for a preclinical liver cancer model, with the unique benefit of suppressing tumor angiogenesis following embolization.Keywords: hepatocellular carcinoma, donafenib, transcatheter arterial chemoembolization, tumor angiogenesis, efficacy, safety |
format |
article |
author |
Li T Shi Q Liu J Wang Y Zhou C Wang C Ju S Huang S Yang C Chen Y Bai Y Xiong B |
author_facet |
Li T Shi Q Liu J Wang Y Zhou C Wang C Ju S Huang S Yang C Chen Y Bai Y Xiong B |
author_sort |
Li T |
title |
Donafenib-Loaded Callispheres Beads Embolization in a VX2 Liver Tumor: Investigating Efficacy, Safety, and Improvement of Tumor Angiogenesis After Embolization |
title_short |
Donafenib-Loaded Callispheres Beads Embolization in a VX2 Liver Tumor: Investigating Efficacy, Safety, and Improvement of Tumor Angiogenesis After Embolization |
title_full |
Donafenib-Loaded Callispheres Beads Embolization in a VX2 Liver Tumor: Investigating Efficacy, Safety, and Improvement of Tumor Angiogenesis After Embolization |
title_fullStr |
Donafenib-Loaded Callispheres Beads Embolization in a VX2 Liver Tumor: Investigating Efficacy, Safety, and Improvement of Tumor Angiogenesis After Embolization |
title_full_unstemmed |
Donafenib-Loaded Callispheres Beads Embolization in a VX2 Liver Tumor: Investigating Efficacy, Safety, and Improvement of Tumor Angiogenesis After Embolization |
title_sort |
donafenib-loaded callispheres beads embolization in a vx2 liver tumor: investigating efficacy, safety, and improvement of tumor angiogenesis after embolization |
publisher |
Dove Medical Press |
publishDate |
2021 |
url |
https://doaj.org/article/5852c3c6defc41ddbb167c0395106f11 |
work_keys_str_mv |
AT lit donafenibloadedcallispheresbeadsembolizationinavx2livertumorinvestigatingefficacysafetyandimprovementoftumorangiogenesisafterembolization AT shiq donafenibloadedcallispheresbeadsembolizationinavx2livertumorinvestigatingefficacysafetyandimprovementoftumorangiogenesisafterembolization AT liuj donafenibloadedcallispheresbeadsembolizationinavx2livertumorinvestigatingefficacysafetyandimprovementoftumorangiogenesisafterembolization AT wangy donafenibloadedcallispheresbeadsembolizationinavx2livertumorinvestigatingefficacysafetyandimprovementoftumorangiogenesisafterembolization AT zhouc donafenibloadedcallispheresbeadsembolizationinavx2livertumorinvestigatingefficacysafetyandimprovementoftumorangiogenesisafterembolization AT wangc donafenibloadedcallispheresbeadsembolizationinavx2livertumorinvestigatingefficacysafetyandimprovementoftumorangiogenesisafterembolization AT jus donafenibloadedcallispheresbeadsembolizationinavx2livertumorinvestigatingefficacysafetyandimprovementoftumorangiogenesisafterembolization AT huangs donafenibloadedcallispheresbeadsembolizationinavx2livertumorinvestigatingefficacysafetyandimprovementoftumorangiogenesisafterembolization AT yangc donafenibloadedcallispheresbeadsembolizationinavx2livertumorinvestigatingefficacysafetyandimprovementoftumorangiogenesisafterembolization AT cheny donafenibloadedcallispheresbeadsembolizationinavx2livertumorinvestigatingefficacysafetyandimprovementoftumorangiogenesisafterembolization AT baiy donafenibloadedcallispheresbeadsembolizationinavx2livertumorinvestigatingefficacysafetyandimprovementoftumorangiogenesisafterembolization AT xiongb donafenibloadedcallispheresbeadsembolizationinavx2livertumorinvestigatingefficacysafetyandimprovementoftumorangiogenesisafterembolization |
_version_ |
1718376852248068096 |